Swiss National Bank
AMED

Swiss National Bank’s Amedisys AMED Stock Holding History

Swiss National Bank’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-62,700
Closed -$6.17M – 2316
2025
Q2 		$6.17M Sell
62,700
-800
-1% -$75.7K ﹤0.01% 1162
2025
Q1 		$5.88M Sell
63,500
-900
-1% -$83K ﹤0.01% 1168
2024
Q4 		$5.85M Buy
64,400
+600
+0.9% +$55.1K ﹤0.01% 1232
2024
Q3 		$6.16M Sell
63,800
-600
-0.9% -$58.5K ﹤0.01% 1194
2024
Q2 		$5.91M Hold
64,400
– – ﹤0.01% 1168
2024
Q1 		$5.94M Buy
64,400
+3,300
+5% +$309K ﹤0.01% 1185
2023
Q4 		$5.81M Sell
61,100
-10,600
-15% -$990K ﹤0.01% 1193
2023
Q3 		$6.7M Buy
71,700
+800
+1% +$73.9K 0.01% 1104
2023
Q2 		$6.48M Buy
70,900
+700
+1% +$57.4K ﹤0.01% 1149
2023
Q1 		$5.16M Sell
70,200
-8,100
-10% -$701K ﹤0.01% 1253
2022
Q4 		$6.54M Buy
78,300
+1,100
+1% +$99.2K ﹤0.01% 1150
2022
Q3 		$7.47M Buy
77,200
+600
+0.8% +$71.5K 0.01% 1044
2022
Q2 		$8.05M Sell
76,600
-500
-0.6% -$63.9K 0.01% 1033
2022
Q1 		$13.3M Buy
77,100
+5,200
+7% +$777K 0.01% 845
2021
Q4 		$11.6M Sell
71,900
-100
-0.1% -$16.1K 0.01% 926
2021
Q3 		$10.7M Sell
72,000
-400
-0.6% -$83.2K 0.01% 965
2021
Q2 		$17.7M Sell
72,400
-2,600
-3% -$682K 0.01% 739
2021
Q1 		$19.9M Buy
75,000
+1,600
+2% +$451K 0.01% 693
2020
Q4 		$21.5M Hold
73,400
– – 0.02% 641
2020
Q3 		$17.4M Buy
73,400
+1,200
+2% +$273K 0.01% 640
2020
Q2 		$14.3M Buy
72,200
+9,600
+15% +$1.79M 0.01% 654
2020
Q1 		$11.5M Buy
62,600
+1,100
+2% +$196K 0.01% 639
2019
Q4 		$10.3M Buy
61,500
+1,300
+2% +$193K 0.01% 758
2019
Q3 		$7.89M Buy
60,200
+600
+1% +$78.1K 0.01% 858
2019
Q2 		$7.24M Buy
59,600
+10,200
+21% +$1.21M 0.01% 907
2019
Q1 		$6.09M Buy
49,400
+1,600
+3% +$201K 0.01% 968
2018
Q4 		$5.6M Sell
47,800
-2,400
-5% -$283K 0.01% 921
2018
Q3 		$6.27M Hold
50,200
– – 0.01% 975
2018
Q2 		$4.29M Hold
50,200
– – ﹤0.01% 1206
2018
Q1 		$3.03M Buy
50,200
+1,200
+2% +$68.4K ﹤0.01% 1365
2017
Q4 		$2.58M Buy
49,000
+1,500
+3% +$79K ﹤0.01% 1480
2017
Q3 		$2.66M Hold
47,500
– – ﹤0.01% 1432
2017
Q2 		$2.98M Buy
47,500
+3,200
+7% +$186K ﹤0.01% 1332
2017
Q1 		$2.26M Buy
44,300
+800
+2% +$38.2K ﹤0.01% 1486
2016
Q4 		$1.85M Hold
43,500
– – ﹤0.01% 1603
2016
Q3 		$2.06M Sell
43,500
-3,200
-7% -$160K ﹤0.01% 1485
2016
Q2 		$2.36M Buy
46,700
+3,100
+7% +$156K ﹤0.01% 1384
2016
Q1 		$2.04M Buy
43,600
+7,700
+21% +$297K ﹤0.01% 1438
2015
Q4 		$1.41M Hold
35,900
– – ﹤0.01% 1569
2015
Q3 		$1.36M Buy
35,900
+4,400
+14% +$186K ﹤0.01% 1572
2015
Q2 		$1.25M Sell
31,500
-1,900
-6% -$59.2K ﹤0.01% 1649
2015
Q1 		$894K Hold
33,400
– – ﹤0.01% 1820
2014
Q4 		$980K Buy
33,400
+700
+2% +$17.3K ﹤0.01% 1740
2014
Q3 		$660K Hold
32,700
– – ﹤0.01% 1921
2014
Q2 		$547K Sell
32,700
-4,300
-12% -$60.9K ﹤0.01% 2116
2014
Q1 		$551K Buy
37,000
+8,800
+31% +$135K ﹤0.01% 2075
2013
Q4 		$413K Hold
28,200
– – ﹤0.01% 2106
2013
Q3 		$486K Sell
28,200
-1,600
-5% -$23.7K ﹤0.01% 1952
2013
Q2 		$346K Buy
+29,800
New +$341K ﹤0.01% 2144

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Swiss National Bank's AMED Position: Q3 2025 in Review

Swiss National Bank sold out of Amedisys (AMED) in Q3 2025, closing a stake of 62,700 shares — an estimated $6.17M sold.

Swiss National Bank first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $21.5M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Swiss National Bank reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Swiss National Bank sold 62,700 Amedisys shares in Q3 2025, an estimated $6.17M.
  • Swiss National Bank first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Swiss National Bank's Amedisys position peaked at $21.5M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Swiss National Bank's 13F filing for Q3 2025, filed 13 Nov 2025.